Matches in SemOpenAlex for { <https://semopenalex.org/work/W4322744740> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W4322744740 endingPage "62" @default.
- W4322744740 startingPage "53" @default.
- W4322744740 abstract "Relevance. The problem of antiplatelet therapy resistance is not fully solved, whereas its manifestations in the form of stent thrombosis cause a negative contribution in treatment and can lead to significant economic damage to the healthcare system. Pharmacogenetic testing as a personalization tool can potentially reduce the cost of treatment, which requires pharmacoeconomic research of pharmacogenetic methods. The aim of this study was a pharmacoeconomic evaluation of the pharmacogenetic testing implementation before the antiplatelet therapy in patients with acute coronary syndrome after percutaneous coronary intervention. Methods. In our study, a decision tree model was built with a time horizon of 1 year and a cost-effectiveness analysis was performed for six compared treatment strategies in patients with acute coronary syndrome after stent implantation with and without genotyping for the drugs clopidogrel, ticagrelor and prasugrel. Results. A treatment strategy with pharmacogenetic testing and the choosing of prasugrel for slow and intermediate metabolizers was the most preferred with CER 35 577.40 rubles per 1 unit of effectiveness. The most expensive strategy was the “blind” use of ticagrelor for all patients. Conclusion. Based on the modeling results, it can be concluded that the implementation of pharmacogenetic testing before prescribing antiplatelet drugs in patients with acute coronary syndrome undergoing stenting can potentially reduce the incidence of adverse events such as stent thrombosis and reduce the overall cost of treatment." @default.
- W4322744740 created "2023-03-03" @default.
- W4322744740 creator A5006411663 @default.
- W4322744740 creator A5031109054 @default.
- W4322744740 creator A5051489878 @default.
- W4322744740 date "2023-02-27" @default.
- W4322744740 modified "2023-10-01" @default.
- W4322744740 title "Pharmacoeconomic analysis of personalized antiplatelet therapy in patients with acute coronary syndromer" @default.
- W4322744740 cites W1709234658 @default.
- W4322744740 cites W1913813468 @default.
- W4322744740 cites W1981978891 @default.
- W4322744740 cites W1985059672 @default.
- W4322744740 cites W2062245141 @default.
- W4322744740 cites W2128228188 @default.
- W4322744740 cites W2140501627 @default.
- W4322744740 cites W2150740314 @default.
- W4322744740 cites W2169387542 @default.
- W4322744740 cites W2483809052 @default.
- W4322744740 cites W2580858561 @default.
- W4322744740 cites W2734275466 @default.
- W4322744740 cites W2765954316 @default.
- W4322744740 cites W2793753528 @default.
- W4322744740 cites W2808924524 @default.
- W4322744740 cites W2936489929 @default.
- W4322744740 cites W2954269000 @default.
- W4322744740 cites W2965540965 @default.
- W4322744740 cites W2976069576 @default.
- W4322744740 cites W2976967554 @default.
- W4322744740 cites W2996266378 @default.
- W4322744740 cites W4207040168 @default.
- W4322744740 cites W4319291138 @default.
- W4322744740 doi "https://doi.org/10.37489/2588-0527-2022-1-53-62" @default.
- W4322744740 hasPublicationYear "2023" @default.
- W4322744740 type Work @default.
- W4322744740 citedByCount "0" @default.
- W4322744740 crossrefType "journal-article" @default.
- W4322744740 hasAuthorship W4322744740A5006411663 @default.
- W4322744740 hasAuthorship W4322744740A5031109054 @default.
- W4322744740 hasAuthorship W4322744740A5051489878 @default.
- W4322744740 hasBestOaLocation W43227447401 @default.
- W4322744740 hasConcept C104317684 @default.
- W4322744740 hasConcept C126322002 @default.
- W4322744740 hasConcept C135763542 @default.
- W4322744740 hasConcept C177713679 @default.
- W4322744740 hasConcept C185592680 @default.
- W4322744740 hasConcept C2776738588 @default.
- W4322744740 hasConcept C2777028646 @default.
- W4322744740 hasConcept C2777698277 @default.
- W4322744740 hasConcept C2777849778 @default.
- W4322744740 hasConcept C2780400711 @default.
- W4322744740 hasConcept C2780890252 @default.
- W4322744740 hasConcept C500558357 @default.
- W4322744740 hasConcept C55493867 @default.
- W4322744740 hasConcept C55775858 @default.
- W4322744740 hasConcept C71924100 @default.
- W4322744740 hasConceptScore W4322744740C104317684 @default.
- W4322744740 hasConceptScore W4322744740C126322002 @default.
- W4322744740 hasConceptScore W4322744740C135763542 @default.
- W4322744740 hasConceptScore W4322744740C177713679 @default.
- W4322744740 hasConceptScore W4322744740C185592680 @default.
- W4322744740 hasConceptScore W4322744740C2776738588 @default.
- W4322744740 hasConceptScore W4322744740C2777028646 @default.
- W4322744740 hasConceptScore W4322744740C2777698277 @default.
- W4322744740 hasConceptScore W4322744740C2777849778 @default.
- W4322744740 hasConceptScore W4322744740C2780400711 @default.
- W4322744740 hasConceptScore W4322744740C2780890252 @default.
- W4322744740 hasConceptScore W4322744740C500558357 @default.
- W4322744740 hasConceptScore W4322744740C55493867 @default.
- W4322744740 hasConceptScore W4322744740C55775858 @default.
- W4322744740 hasConceptScore W4322744740C71924100 @default.
- W4322744740 hasIssue "1" @default.
- W4322744740 hasLocation W43227447401 @default.
- W4322744740 hasOpenAccess W4322744740 @default.
- W4322744740 hasPrimaryLocation W43227447401 @default.
- W4322744740 hasRelatedWork W2366835925 @default.
- W4322744740 hasRelatedWork W2473576731 @default.
- W4322744740 hasRelatedWork W2566822712 @default.
- W4322744740 hasRelatedWork W2790813266 @default.
- W4322744740 hasRelatedWork W2909895200 @default.
- W4322744740 hasRelatedWork W2947514663 @default.
- W4322744740 hasRelatedWork W4224250870 @default.
- W4322744740 hasRelatedWork W4366083222 @default.
- W4322744740 hasRelatedWork W68793142 @default.
- W4322744740 hasRelatedWork W2072549250 @default.
- W4322744740 isParatext "false" @default.
- W4322744740 isRetracted "false" @default.
- W4322744740 workType "article" @default.